AbCellera Biologics Inc.
Developer of an integrated antibody discovery and development platform that combines microfluidics-based single-cell screening, high-throughput sequencing, automated instrumentation, data science and protein science with CMC and clinical manufacturing capabilities. The platform supports target assessment, discovery, IND-enabling studies and early clinical manufacturing. The company has operated through partnerships on 100+ discovery programs and has shifted toward advancing internal and co-development therapeutic antibody programs.
Industries
Nr. of Employees
large (251-1000)
AbCellera Biologics Inc.
Products
Internal therapeutic antibody programs (clinical-stage candidates)
In-house discovery-to-IND therapeutic antibody programs advanced using the integrated platform; programs include candidates targeting GPCRs and immune targets with engineered Fc modifications.
Internal therapeutic antibody programs (clinical-stage candidates)
In-house discovery-to-IND therapeutic antibody programs advanced using the integrated platform; programs include candidates targeting GPCRs and immune targets with engineered Fc modifications.
Services
End-to-end antibody discovery and development
Integrated workflows from target assessment, single-cell functional screening, sequence analysis, protein engineering and preclinical characterization through IND-enabling studies.
Partnerships, licensing and alliance management
Structuring and managing research collaborations, licensing of assets, and alliance governance to advance antibody programs with partners.
CMC and clinical manufacturing development
Design, build, qualification and operational support for clinical CMC laboratories and GMP manufacturing facilities to produce drug substance and drug product for clinical trials.
End-to-end antibody discovery and development
Integrated workflows from target assessment, single-cell functional screening, sequence analysis, protein engineering and preclinical characterization through IND-enabling studies.
Partnerships, licensing and alliance management
Structuring and managing research collaborations, licensing of assets, and alliance governance to advance antibody programs with partners.
CMC and clinical manufacturing development
Design, build, qualification and operational support for clinical CMC laboratories and GMP manufacturing facilities to produce drug substance and drug product for clinical trials.
Expertise Areas
- Therapeutic antibody discovery and engineering
- Single-cell screening and high-throughput functional assays
- Target assessment and prioritization
- Protein expression for complex membrane proteins
Key Technologies
- Microfluidic single-cell screening
- Immune-repertoire / next-generation sequencing
- Automation and machine-vision imaging for screening
- Cloud-scale data pipelines and ML-driven bioinformatics